Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01054885 · COMPLETED
Trial details
- NCT number
- NCT01054885
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-19
- Primary completion
- 2011-02-01
- Enrollment
- 1226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.